AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 223 filers reported holding AXSOME THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $21,558 | +16.5% | 300 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $18,504 | -20.0% | 300 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $23,139 | -48.6% | 300 | -70.0% | 0.00% | -50.0% |
| Q3 2022 | $45,000 | -41.6% | 1,000 | -50.0% | 0.01% | -33.3% |
| Q2 2022 | $77,000 | -25.2% | 2,000 | -20.0% | 0.01% | -18.2% |
| Q1 2022 | $103,000 | +9.6% | 2,500 | 0.0% | 0.01% | +10.0% |
| Q4 2021 | $94,000 | +14.6% | 2,500 | 0.0% | 0.01% | +11.1% |
| Q3 2021 | $82,000 | -51.5% | 2,500 | 0.0% | 0.01% | -52.6% |
| Q2 2021 | $169,000 | +19.0% | 2,500 | 0.0% | 0.02% | +11.8% |
| Q1 2021 | $142,000 | -30.4% | 2,500 | 0.0% | 0.02% | -41.4% |
| Q4 2020 | $204,000 | +14.6% | 2,500 | 0.0% | 0.03% | 0.0% |
| Q3 2020 | $178,000 | -13.6% | 2,500 | 0.0% | 0.03% | -19.4% |
| Q2 2020 | $206,000 | +40.1% | 2,500 | 0.0% | 0.04% | +20.0% |
| Q1 2020 | $147,000 | – | 2,500 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |